Aemetis Financials
Aemetis (AMTX) reported $197.6M in revenue for fiscal year 2025, down 26.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Negative gross margins keep the business dependent on working-capital swings and external financing rather than self-funded operations.
Operating cash flow turned positive at$3.3M even though gross margin stayed negative at-0.4% , suggesting cash improved because balance-sheet items unwound rather than because each sale became meaningfully profitable. The clearest clue is inventory liquidation: inventory fell from$25.4M to$11.6M while free cash flow still stayed below zero.
With interest expense at
The liquidity posture is extremely tight: a current ratio of 0.07x means near-term obligations far exceed near-term resources. Even after the cash-flow improvement, capital spending of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aemetis's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Aemetis, and counted as zero in the overall score.
Not available for Aemetis, and counted as zero in the overall score.
Aemetis scores -4.61, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($129.9M) relative to total liabilities ($566.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aemetis passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
Aemetis reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Aemetis reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Aemetis generated $197.6M in revenue in fiscal year 2025. This represents a decrease of 26.2% from the prior year.
Aemetis's EBITDA was -$27.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 13.8% from the prior year.
Aemetis reported -$77.0M in net income in fiscal year 2025. This represents an increase of 12.0% from the prior year.
Aemetis earned -$1.28 per diluted share (EPS) in fiscal year 2025. This represents an increase of 33.0% from the prior year.
Cash & Balance Sheet
Aemetis recorded an outflow of $22.7M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 57.2% from the prior year.
Aemetis held $4.9M in cash against $63.9M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Aemetis's gross margin was -0.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the prior year.
Aemetis's operating margin was -18.8% in fiscal year 2025, reflecting core business profitability. This is down 3.7 percentage points from the prior year.
Aemetis's net profit margin was -39.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 6.3 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Aemetis invested $26.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 28.4% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
AMTX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $219.8M | $197.6M-26.2% | $267.6M+246.7% | $77.2M-69.9% | $256.5M+21.0% | $211.9M+28.0% | $165.6M-18.0% | $202.0M+17.8% | $171.5M+14.2% | $150.2M+4.9% | $143.2M-2.4% | $146.6M-29.4% | $207.7M+17.0% | $177.5M-6.1% | $189.0M+33.3% | $141.9M |
| Cost of Revenue | $206.2M | $208.7M-22.2% | $268.2M+45.2% | $184.7M-29.5% | $262.0M+28.4% | $204.0M+32.0% | $154.5M-18.4% | $189.3M+14.0% | $166.1M+13.2% | $146.8M+11.6% | $131.6M-7.6% | $142.4M-16.5% | $170.5M+7.1% | $159.2M-19.6% | $198.0M+44.3% | $137.2M |
| Gross Profit | $13.6M | -$768K-32.4% | -$580K+99.5% | -$107.5M-1842.3% | -$5.5M-169.7% | $7.9M-28.0% | $11.0M-13.2% | $12.7M+134.9% | $5.4M+60.1% | $3.4M-70.9% | $11.6M+176.2% | $4.2M-88.7% | $37.1M+103.0% | $18.3M+304.9% | -$8.9M-292.3% | $4.6M |
| R&D Expenses | N/A | N/A | N/A | $152K-15.6% | $180K+104.5% | $88K-58.7% | $213K+3.9% | $205K-16.7% | $246K-89.6% | $2.4M+541.5% | $369K-17.4% | $447K-2.6% | $459K-14.8% | $539K-13.1% | $620K+7.5% | $577K |
| SG&A Expenses | $35.5M | $36.5M-8.5% | $39.8M+1.1% | $39.4M+37.4% | $28.7M+21.2% | $23.7M+40.2% | $16.9M-3.1% | $17.4M+8.3% | $16.1M+21.9% | $13.2M+9.8% | $12.0M-2.8% | $12.4M-1.9% | $12.6M-17.5% | $15.3M+31.5% | $11.6M+35.5% | $8.6M |
| Operating Income | -$11.6M | -$37.2M+7.9% | -$40.4M-8.1% | -$37.4M-8.7% | -$34.4M-117.4% | -$15.8M-160.7% | -$6.1M-23.1% | -$4.9M+54.9% | -$10.9M+10.3% | -$12.2M-1459.9% | -$781K+90.9% | -$8.6M-135.7% | $24.1M+871.4% | $2.5M+111.7% | -$21.2M-369.7% | -$4.5M |
| Interest Expense | $54.9M | $52.9M+13.5% | $46.6M+18.0% | $39.5M+37.4% | $28.8M+19.6% | $24.1M+4.9% | $22.9M+8.8% | $21.1M-17.9% | $25.7M+33.1% | $19.3M+12.1% | $17.2M+69.4% | $10.2M+1.1% | $10.1M-14.9% | $11.8M-33.1% | $17.7M+30.2% | $13.6M |
| Income Tax | -$11.6M | -$18.7M-73.1% | -$10.8M+79.8% | -$53.7M-5203.1% | $1.1M+922.7% | -$128K+86.9% | -$976K-186.3% | $1.1M+16057.1% | $7K+16.7% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K+100.6% | -$1.1M-1034.6% | -$95K |
| Net Income | -$60.2M | -$77.0M+12.0% | -$87.5M-88.6% | -$46.4M+56.9% | -$107.8M-128.6% | -$47.1M-28.6% | -$36.7M+7.1% | -$39.5M-8.8% | -$36.3M-14.2% | -$31.8M-103.2% | -$15.6M+42.4% | -$27.1M-480.5% | $7.1M+129.2% | -$24.4M-470.7% | -$4.3M+76.6% | -$18.3M |
| EPS (Diluted) | — | -$1.28+33.0% | -$1.91-56.6% | -$1.22+60.9% | -$3.12-102.6% | -$1.54 | -$1.74+0.6% | -$1.75-7.4% | -$1.63-6.5% | -$1.53-93.7% | -$0.79+42.3% | -$1.37-502.9% | $0.34+126.6% | -$1.28 | -$0.28 | -$0.18 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AMTX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $259.8M+0.2% | $259.3M+6.5% | $243.4M+17.5% | $207.1M+28.8% | $160.8M+28.5% | $125.1M+25.3% | $99.9M+8.8% | $91.8M-2.7% | $94.3M+21.2% | $77.8M-6.4% | $83.1M-6.8% | $89.2M-8.2% | $97.1M+0.3% | $96.9M+255.9% | $27.2M |
| Current Assets | $26.9M-39.9% | $44.7M+22.8% | $36.4M+100.7% | $18.1M-12.4% | $20.7M+138.3% | $8.7M-31.0% | $12.6M+22.0% | $10.3M-10.0% | $11.5M+62.7% | $7.0M-12.0% | $8.0M+0.9% | $7.9M-37.6% | $12.7M+85.6% | $6.8M-4.0% | $7.1M |
| Cash & Equivalents | $4.9M+445.0% | $898K-66.3% | $2.7M-38.2% | $4.3M-44.4% | $7.8M+1209.3% | $592K-9.8% | $656K-44.8% | $1.2M+177.6% | $428K-71.2% | $1.5M+425.1% | $283K-14.8% | $332K-93.3% | $4.9M+1592.8% | $291K+16.9% | $249K |
| Inventory | $11.6M-54.3% | $25.4M+39.1% | $18.3M+292.7% | $4.7M-9.1% | $5.1M+29.2% | $4.0M-39.1% | $6.5M+6.3% | $6.1M+6.8% | $5.7M+77.0% | $3.2M-32.5% | $4.8M+7.0% | $4.5M+9.6% | $4.1M-10.0% | $4.6M+14.4% | $4.0M |
| Accounts Receivable | $500K-72.2% | $1.8M-79.1% | $8.6M+580.4% | $1.3M-19.7% | $1.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $968K | N/A | N/A | N/A |
| Total Liabilities | $566.7M+8.3% | $523.2M+13.7% | $460.4M+12.6% | $409.0M+45.5% | $281.1M-9.3% | $309.9M+21.9% | $254.3M+22.6% | $207.4M+20.1% | $172.7M+35.3% | $127.6M+7.8% | $118.4M+28.5% | $92.1M-16.2% | $109.9M+17.7% | $93.4M+88.9% | $49.4M |
| Current Liabilities | $371.3M+157.9% | $144.0M+70.6% | $84.4M-4.4% | $88.3M+35.1% | $65.3M-36.1% | $102.2M+76.8% | $57.8M+35.8% | $42.6M+18.2% | $36.0M+32.3% | $27.2M-7.1% | $29.3M+7.3% | $27.3M-24.4% | $36.1M-37.6% | $57.8M+96.5% | $29.4M |
| Long-Term Debt | $63.9M-74.2% | $247.5M-3.9% | $257.7M+30.8% | $197.0M+18.7% | $166.0M-2.4% | $170.1M-5.3% | $179.7M+13.9% | $157.8M+14.2% | $138.2M+37.7% | $100.3M+12.8% | $88.9M+37.8% | $64.6M-12.5% | $73.8M+184.3% | $26.0M+29.8% | $20.0M |
| Total Equity | -$306.8M-16.3% | -$263.9M-21.6% | -$217.0M-7.5% | -$201.9M-67.9% | -$120.2M+34.9% | -$184.7M-19.7% | -$154.4M-33.6% | -$115.6M-47.4% | -$78.4M-57.4% | -$49.8M-41.1% | -$35.3M-1087.6% | -$3.0M+76.7% | -$12.8M-463.3% | $3.5M+115.8% | -$22.2M |
| Retained Earnings | -$639.9M-13.7% | -$562.9M-18.4% | -$475.4M-10.8% | -$429.0M-33.5% | -$321.2M-17.2% | -$274.1M-15.4% | -$237.4M-22.9% | -$193.2M-20.6% | -$160.2M-23.3% | -$129.9M-13.7% | -$114.3M-31.2% | -$87.1M+7.6% | -$94.2M-35.0% | -$69.8M-6.5% | -$65.5M |
AMTX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.6M | $3.3M+109.9% | -$32.9M-338.2% | $13.8M+160.5% | -$22.9M-10.7% | -$20.6M-932.5% | $2.5M+221.9% | -$2.0M+63.1% | -$5.5M+36.6% | -$8.7M-2441.8% | $371K+147.2% | -$786K-103.8% | $20.6M+1323.5% | -$1.7M+90.1% | -$16.9M-1257.8% | -$1.2M |
| Capital Expenditures | $35.7M | $26.0M+28.4% | $20.3M-38.8% | $33.1M-15.4% | $39.2M+46.9% | $26.7M+37.8% | $19.3M+125.5% | $8.6M+110.6% | $4.1M+265.1% | $1.1M+77.4% | $629K+785.9% | $71K-96.4% | $2.0M+54.0% | $1.3M-6.7% | $1.4M-46.7% | $2.6M |
| Free Cash Flow | -$39.3M | -$22.7M+57.2% | -$53.2M-175.6% | -$19.3M+68.9% | -$62.0M-31.1% | -$47.3M-180.5% | -$16.9M-58.9% | -$10.6M-10.8% | -$9.6M+2.3% | -$9.8M-3700.0% | -$258K+69.9% | -$857K-104.6% | $18.6M+729.5% | -$3.0M+83.8% | -$18.3M-379.7% | -$3.8M |
| Investing Cash Flow | -$34.3M | -$25.6M-80.9% | -$14.1M+40.3% | -$23.7M+24.3% | -$31.3M-36.7% | -$22.9M-32.3% | -$17.3M-101.8% | -$8.6M-110.6% | -$4.1M-265.1% | -$1.1M-77.4% | -$629K-785.9% | -$71K+96.4% | -$2.0M-977.2% | $224K+101.4% | -$16.5M-1600.9% | -$968K |
| Financing Cash Flow | $36.9M | $26.4M-40.8% | $44.6M+390.6% | $9.1M-83.0% | $53.6M+5.8% | $50.7M+243.2% | $14.8M+46.5% | $10.1M-2.9% | $10.4M+24.1% | $8.4M+414.8% | $1.6M+99.4% | $816K+103.5% | -$23.2M-471.6% | $6.3M-81.3% | $33.3M+1687.2% | $1.9M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $7.5M | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AMTX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -0.4%-0.2pp | -0.2% | -139.3% | -2.2%-5.9pp | 3.8%-2.9pp | 6.7%+0.4pp | 6.3%+3.1pp | 3.1%+0.9pp | 2.3%-5.9pp | 8.1%+5.2pp | 2.9%-15.0pp | 17.9%+7.6pp | 10.3%+15.0pp | -4.7%-8.0pp | 3.3% |
| Operating Margin | -18.8%-3.7pp | -15.1%+33.4pp | -48.4%-35.0pp | -13.4%-5.9pp | -7.5%-3.8pp | -3.7%-1.2pp | -2.4%+3.9pp | -6.4%+1.7pp | -8.1%-7.6pp | -0.5%+5.3pp | -5.9%-17.5pp | 11.6%+10.2pp | 1.4%+12.6pp | -11.2%-8.0pp | -3.2% |
| Net Margin | -39.0%-6.3pp | -32.7%+27.4pp | -60.1%-18.1pp | -42.0%-19.8pp | -22.2%-0.1pp | -22.1%-2.6pp | -19.5%+1.6pp | -21.2%0.0pp | -21.2%-10.2pp | -10.9%+7.6pp | -18.5%-21.9pp | 3.4%+17.2pp | -13.8%-11.5pp | -2.3%+10.6pp | -12.9% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -121.9% | N/A |
| Return on Assets | -29.6%+4.1pp | -33.8%-14.7pp | -19.1%+33.0pp | -52.0%-22.7pp | -29.3%0.0pp | -29.3%+10.2pp | -39.5%0.0pp | -39.5%-5.8pp | -33.7%-13.6pp | -20.1%+12.5pp | -32.6%-40.6pp | 8.0%+33.2pp | -25.2%-20.7pp | -4.4%+62.8pp | -67.2% |
| Current Ratio | 0.07-0.2x | 0.31-0.1x | 0.43+0.2x | 0.21-0.1x | 0.32+0.2x | 0.08-0.1x | 0.220.0x | 0.24-0.1x | 0.32+0.1x | 0.260.0x | 0.270.0x | 0.29-0.1x | 0.35+0.2x | 0.12-0.1x | 0.24 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 7.39 | N/A |
| FCF Margin | -11.5%+8.4pp | -19.9%+5.1pp | -25.0%-0.8pp | -24.2%-1.9pp | -22.3%-12.1pp | -10.2%-4.9pp | -5.3%+0.3pp | -5.6%+0.9pp | -6.5%-6.3pp | -0.2%+0.4pp | -0.6%-9.6pp | 9.0%+10.6pp | -1.7%+8.0pp | -9.7%-7.0pp | -2.7% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin.
Note: Shareholder equity is negative (-$306.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Aemetis Ranks
Frequently Asked Questions
What is Aemetis's annual revenue?
Aemetis (AMTX) reported $197.6M in total revenue for fiscal year 2025. This represents a -26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Aemetis's revenue growing?
Aemetis (AMTX) revenue declined by 26.2% year-over-year, from $267.6M to $197.6M in fiscal year 2025.
Is Aemetis profitable?
No, Aemetis (AMTX) reported a net income of -$77.0M in fiscal year 2025, with a net profit margin of -39.0%.
What is Aemetis's EBITDA?
Aemetis (AMTX) had EBITDA of -$27.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Aemetis have?
As of fiscal year 2025, Aemetis (AMTX) had $4.9M in cash and equivalents against $63.9M in long-term debt.
What is Aemetis's gross margin?
Aemetis (AMTX) had a gross margin of -0.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Aemetis's operating margin?
Aemetis (AMTX) had an operating margin of -18.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Aemetis's net profit margin?
Aemetis (AMTX) had a net profit margin of -39.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Aemetis's free cash flow?
Aemetis (AMTX) recorded an outflow of $22.7M in free cash flow during fiscal year 2025. This represents a 57.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Aemetis's operating cash flow?
Aemetis (AMTX) generated $3.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Aemetis's total assets?
Aemetis (AMTX) had $259.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Aemetis's capital expenditures?
Aemetis (AMTX) invested $26.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Aemetis's current ratio?
Aemetis (AMTX) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Aemetis's return on assets (ROA)?
Aemetis (AMTX) had a return on assets of -29.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Aemetis's debt-to-equity ratio negative or not reported?
Aemetis (AMTX) has negative shareholder equity of -$306.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Aemetis's Altman Z-Score?
Aemetis (AMTX) has an Altman Z-Score of -4.61, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Aemetis's Piotroski F-Score?
Aemetis (AMTX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Aemetis's earnings high quality?
Aemetis (AMTX) reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Aemetis cover its interest payments?
Aemetis (AMTX) reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Aemetis?
Aemetis (AMTX) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.